Effect and Safety of Fuzheng Huazhuo Decoction against Prolonged SARS-CoV-2 Clearance: A Retrospective Cohort Study
Chinese Journal of Integrative Medicine · 2025
DOI: 10.1007/s11655-024-3921-3 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Chinese Journal of Integrative Medicine, 2025. Verfasst von Wen Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, COVID-19 Drug Treatment, SARS-CoV-2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: To evaluate the effect and safety of Chinese medicine (CM) Fuzheng Huazhuo Decoction (FHD) in treating patients with coronavirus disease 2019 (COVID-19) who persistently tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). METHODS: This retrospective cohort study was conducted at Shanghai New International Expo Center shelter hospital in China between April 1 and May 30, 2022. Patients diagnosed as COVID-19 with persistently positive SARS-CoV-2 reverse transcription-polymerase chain reaction (RT-PCR) test results for ⩾8 days after diagnosis were enrolled. Patients in the control group received conventional Western medicine (WM) treatment, while those in the FHD group received conventional WM plus FHD for at least 3 days. The primary outcome was viral clearance time. Secondary outcomes included negative conversion rate within 14 days, length of hospital stay, cycle threshold (Ct) values of the open reading frame 1ab (ORF1ab) and nucleocapsid protein (N) genes, and incidence of new-onset symptoms during hospitalization. Adverse events (AEs) that occurred during the study period were recorded. RESULTS: A total of 1,765 eligible patients were enrolled in this study (546 in the FHD group and 1,219 in the control group). Compared with the control group, patients receiving FHD treatment showed shorter viral clearance time for nucleic acids [hazard ratio (HR): 1.500, 95% confidence interval (CI): 1.353-1.664, P 0.05). The Ct values of ORF1ab and N genes increased more rapidly over time in the FHD group than those in the control group post-randomization (ORF1ab gene: β =0.436±0.053, P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
- Institute of Emergency and Critical Care Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
- Department of Spleen and Stomach Diseases, Jiujiang Traditional Chinese Medicine Hospital, Jiujiang, Jiangxi Province, 332005, China.
- Department of Rheumatology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
- School of Acupuncture-Moxibustion and Tuina, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
- Department of Emergency, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China. fangbji@163.com.
Zitieren
APA
Zhang, W., Wu, H. Z., Xu, X. R., Pu, Y. T., Chen, C. Y., Deng, R., Cao, M., Sun, D., Yi, H., Zhou, S., & Fang, B. J. (2025). Effect and Safety of Fuzheng Huazhuo Decoction against Prolonged SARS-CoV-2 Clearance: A Retrospective Cohort Study. Chinese Journal of Integrative Medicine. https://doi.org/10.1007/s11655-024-3921-3
Vancouver
Zhang W, Wu HZ, Xu XR, Pu YT, Chen CY, Deng R, et al. Effect and Safety of Fuzheng Huazhuo Decoction against Prolonged SARS-CoV-2 Clearance: A Retrospective Cohort Study. Chinese Journal of Integrative Medicine. 2025. doi:10.1007/s11655-024-3921-3
BibTeX
@article{Zhang2025,
author = {Zhang, Wen and Wu, Hong-Ze and Xu, Xiang-Ru and Pu, Yu-Ting and Chen, Cai-Yu and Deng, Rou and Cao, Min and Sun, Ding and Yi, Hui and Zhou, Shuang and Fang, Bang-Jiang},
title = {Effect and Safety of Fuzheng Huazhuo Decoction against Prolonged SARS-CoV-2 Clearance: A Retrospective Cohort Study},
journal = {Chinese Journal of Integrative Medicine},
year = {2025},
doi = {10.1007/s11655-024-3921-3}
}
EUVIMED